125 related articles for article (PubMed ID: 24139416)
1. Inhibition of lymphatic metastases by a survivin dominant-negative mutant.
Xu GC; Zhang P; Leng F; Pan L; Li ZY; Yu DD; Shan Y; Yuan QZ; Wen Y; Mu B; Shi HS; Chen X; Wang CT
Oncol Res; 2012; 20(12):579-87. PubMed ID: 24139416
[TBL] [Abstract][Full Text] [Related]
2. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-->Ala mutant.
Peng XC; Yang L; Yang LP; Mao YQ; Yang HS; Liu JY; Zhang DM; Chen LJ; Wei YQ
J Exp Clin Cancer Res; 2008 Sep; 27(1):46. PubMed ID: 18816410
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of survivin dominant negative mutant in a mouse model of prostate cancer.
Pan L; Peng XC; Leng F; Yuan QZ; Shan Y; Yu DD; Li ZY; Chen X; Xiao WJ; Wen Y; Ma TT; Yang L; Mao YQ; Yang HS; Wei YQ; Wang CT
J Cancer Res Clin Oncol; 2011 Jan; 137(1):19-28. PubMed ID: 20217127
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
5. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
[TBL] [Abstract][Full Text] [Related]
6. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
Chen JS; Zhang YJ; Hu SE; Zhang HQ
Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
[TBL] [Abstract][Full Text] [Related]
7. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
Wang Z; Lv J; Zhang T
Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor and antimetastatic activities of plasmid pcDNA3. 1-IP10 complexed with cationic liposome in mice with 4T1 breast cancer].
Tang QQ; Shi W; Lü HM; Peng XC; Wen YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):195-8. PubMed ID: 19462888
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.
Yuan QZ; Wang CT; Mao YQ; Zhang P; Shi HS; Li ZY; Pan L; Yu DD; Leng F; Chen X; Ying W; Xu JH; Li W; Wu F; Wen Y; Ma TT; Wei YQ
Oncol Rep; 2010 Jan; 23(1):97-103. PubMed ID: 19956869
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.
Yu DD; Wang CT; Shi HS; Li ZY; Pan L; Yuan QZ; Leng F; Wen Y; Chen X; Wei YQ
J Exp Clin Cancer Res; 2010 May; 29(1):46. PubMed ID: 20462440
[TBL] [Abstract][Full Text] [Related]
11. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
[TBL] [Abstract][Full Text] [Related]
13. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
14. Therapy with siRNA for Vegf-c but not for Vegf-d suppresses wide-spectrum organ metastasis in an immunocompetent xenograft model of metastatic mammary cancer.
Shibata MA; Shibata E; Morimoto J; Harada-Shiba M
Anticancer Res; 2013 Oct; 33(10):4237-47. PubMed ID: 24122987
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.
Roberts N; Kloos B; Cassella M; Podgrabinska S; Persaud K; Wu Y; Pytowski B; Skobe M
Cancer Res; 2006 Mar; 66(5):2650-7. PubMed ID: 16510584
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor effects of matrix protein of vesicular stomatic virus on EL4 lymphoma mice].
Lin SJ; Yu QM; Meng WT; Wen YJ; Chen LJ; Niu T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):213-7. PubMed ID: 21500556
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model.
Shibata MA; Morimoto J; Shibata E; Otsuki Y
Cancer Gene Ther; 2008 Dec; 15(12):776-86. PubMed ID: 18654613
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
Guo B; Zhang Y; Luo G; Li L; Zhang J
Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2009 Oct; 292(10):1577-83. PubMed ID: 19685508
[TBL] [Abstract][Full Text] [Related]
20. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
